IKBIP as a prognostic biomarker and immunotherapeutic target regulates the JAK-STAT3 signaling pathway to promote cervical cancer - PubMed
5 hours ago
- #JAK-STAT3 Pathway
- #Immunotherapy
- #Cervical Cancer
- IKBIP identified as a prognostic biomarker and immunotherapeutic target in cervical cancer.
- Study shows IKBIP regulates the JAK-STAT3 signaling pathway to promote cervical cancer progression.
- Research conducted with ethical approval from Shihezi University and informed consent from participants.
- Authors declare no competing interests and have consented to publication.
- Supported by multiple grants including the National Natural Science Foundation of China and Tianshan Talent Program.